These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 36074324)

  • 21. CircPUM1 promotes cell growth and glycolysis in NSCLC via up-regulating METTL3 expression through miR-590-5p.
    Li M; Wang Q; Zhang X; Yan N; Li X
    Cell Cycle; 2021 Jul; 20(13):1279-1294. PubMed ID: 34097560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. METTL3-mediated m6A modification promotes processing and maturation of
    Gong Y; Jiang Q; Liu L; Liao Q; Yu J; Xiang Z; Luo X
    Physiol Genomics; 2022 Sep; 54(9):337-349. PubMed ID: 35759451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. m6A-mediated lncRNA NEAT1 plays an oncogenic role in non-small cell lung cancer by upregulating the HMGA1 expression through binding miR-361-3p.
    Qi L; Yin Y; Sun M
    Genes Genomics; 2023 Dec; 45(12):1537-1547. PubMed ID: 37688756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N(6)-methyladenosine-mediated miR-380-3p maturation and upregulation promotes cancer aggressiveness in pancreatic cancer.
    Jiang Z; Song X; Wei Y; Li Y; Kong D; Sun J
    Bioengineered; 2022 Jun; 13(6):14460-14471. PubMed ID: 35758158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth.
    Wu S; Wang H; Yang Q; Liu Z; Du J; Wang L; Chen S; Lu Q; Yang DH
    Cancer Lett; 2024 Aug; 597():217058. PubMed ID: 38880226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-338-5p inhibits cell growth and migration via inhibition of the METTL3/m6A/c-Myc pathway in lung cancer.
    Wu H; Li F; Zhu R
    Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):304-316. PubMed ID: 33355622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. METTL3-driven m6A modification of lncRNA FAM230B suppresses ferroptosis by modulating miR-27a-5p/BTF3 axis in gastric cancer.
    Cui Y; Pu M; Gong Y; Li R; Wang X; Ye J; Huang H; Liao D; Yang Y; Yin A; Li J; Deng Y; Tian Z; Pu R
    Biochim Biophys Acta Gen Subj; 2024 Nov; 1868(11):130714. PubMed ID: 39278369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. METTL3 promotes IL-1β-induced degeneration of endplate chondrocytes by driving m6A-dependent maturation of miR-126-5p.
    Xiao L; Zhao Q; Hu B; Wang J; Liu C; Xu H
    J Cell Mol Med; 2020 Dec; 24(23):14013-14025. PubMed ID: 33098220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis.
    Chu S; Li Y; Wu B; Rong G; Hou Q; Zhou Q; Du D; Li Y
    Cell Transplant; 2023; 32():9636897231188300. PubMed ID: 37606168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
    Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
    Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N6-methyladenosine modification in trophoblasts promotes circSETD2 expression, inhibits miR-181a-5p, and elevates MCL1 transcription to reduce apoptosis of trophoblasts.
    Wang D; Guan H; Wang Y; Song G; Xia Y
    Environ Toxicol; 2023 Feb; 38(2):422-435. PubMed ID: 36260529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
    Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H
    Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. METTL3/LINC00662/miR-186-5p feedback loop regulates docetaxel resistance in triple negative breast cancer.
    Jing L; Lan L; Mingxin Z; Zhaofeng Z
    Sci Rep; 2022 Oct; 12(1):16715. PubMed ID: 36202872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CircSLC8A1 targets miR-181a-5p/HIF1AN pathway to inhibit the growth, migration and extracellular matrix deposition of human keloid fibroblasts.
    Yuan X; Chen B; Wang X
    Burns; 2023 May; 49(3):622-632. PubMed ID: 35610079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FTO-stabilized miR-139-5p targets ZNF217 to suppress prostate cancer cell malignancies by inactivating the PI3K/Akt/mTOR signal pathway.
    Azhati B; Reheman A; Dilixiati D; Rexiati M
    Arch Biochem Biophys; 2023 Jun; 741():109604. PubMed ID: 37080415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. METTL3-mediated m
    Ji G; Wang X; Xi H
    Int J Immunopathol Pharmacol; 2023; 37():3946320231204694. PubMed ID: 37823387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencing of SNHG6 alleviates hypoxia/reoxygenation-induced cardiomyocyte apoptosis by modulating miR-135a-5p/HIF1AN to activate Shh/Gli1 signalling pathway.
    Lang Z; Fan X; Lin H; Qiu L; Zhang J; Gao C
    J Pharm Pharmacol; 2021 Mar; 73(1):22-31. PubMed ID: 33791813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Verbascoside inhibits oral squamous cell carcinoma cell proliferation, migration, and invasion by the methyltransferase 3-mediated microRNA-31-5p/homeodomain interacting protein kinase 2 axis.
    Huang Y; Wu W; Zhang X
    Arch Oral Biol; 2024 Aug; 164():105979. PubMed ID: 38744201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silencing METTL3 Stabilizes Atherosclerotic Plaques by Regulating the Phenotypic Transformation of Vascular Smooth Muscle Cells via the miR-375-3p/PDK1 Axis.
    Chen J; Lai K; Yong X; Yin H; Chen Z; Wang H; Chen K; Zheng J
    Cardiovasc Drugs Ther; 2023 Jun; 37(3):471-486. PubMed ID: 35704246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-186-5p prevents hepatocellular carcinoma progression by targeting methyltransferase-like 3 that regulates m6A-mediated stabilization of follistatin-like 5.
    Ma S; Chen F; Lin C; Sun W; Wang D; Zhou S; Chang S; Lu Z; Zhang D
    Heliyon; 2024 Mar; 10(5):e26767. PubMed ID: 38463829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.